Csenge Advisory Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.62M | Sell |
18,196
-149
| -0.8% | -$34.7K | 0.19% | 111 |
|
|
2026
Q1 | $4.48M | Sell |
18,345
-2,768
| -13% | -$645K | 0.21% | 96 |
|
|
2025
Q4 | $4.37M | Sell |
21,113
-741
| -3% | -$147K | 0.2% | 102 |
|
|
2025
Q3 | $4.05M | Buy |
21,854
+226
| +1% | +$38.7K | 0.19% | 99 |
|
|
2025
Q2 | $3.36M | Buy |
21,628
+2,566
| +13% | +$394K | 0.18% | 107 |
|
|
2025
Q1 | $3M | Buy |
19,062
+502
| +3% | +$78.5K | 0.17% | 112 |
|
|
2024
Q4 | $2.68M | Sell |
18,560
-3,283
| -15% | -$509K | 0.15% | 118 |
|
|
2024
Q3 | $3.53M | Sell |
21,843
-1,032
| -5% | -$164K | 0.18% | 100 |
|
|
2024
Q2 | $3.34M | Buy |
22,875
+1,090
| +5% | +$162K | 0.19% | 99 |
|
|
2024
Q1 | $3.45M | Sell |
21,785
-127
| -0.6% | -$20.2K | 0.19% | 100 |
|
|
2023
Q4 | $3.43M | Sell |
21,912
-2,349
| -10% | -$360K | 0.21% | 83 |
|
|
2023
Q3 | $3.78M | Sell |
24,261
-5,121
| -17% | -$845K | 0.26% | 71 |
|
|
2023
Q2 | $4.86M | Buy |
29,382
+2,401
| +9% | +$388K | 0.33% | 61 |
|
|
2023
Q1 | $4.18M | Buy |
26,981
+89
| +0.3% | +$14.4K | 0.3% | 69 |
|
|
2022
Q4 | $4.75M | Sell |
26,892
-219
| -0.8% | -$37.8K | 0.37% | 58 |
|
|
2022
Q3 | $4.43M | Buy |
27,111
+1,011
| +4% | +$171K | 0.37% | 60 |
|
|
2022
Q2 | $4.63M | Buy |
26,100
+615
| +2% | +$110K | 0.39% | 54 |
|
|
2022
Q1 | $4.52M | Sell |
25,485
-3,242
| -11% | -$552K | 0.36% | 57 |
|
|
2021
Q4 | $4.77M | Buy |
28,727
+2,637
| +10% | +$432K | 0.42% | 49 |
|
|
2021
Q3 | $4.19M | Sell |
26,090
-2,637
| -9% | -$450K | 0.35% | 59 |
|
|
2021
Q2 | $4.77M | Buy |
28,727
+4,524
| +19% | +$749K | 0.42% | 49 |
|
|
2021
Q1 | $3.9M | Buy |
24,203
+5,727
| +31% | +$927K | 0.4% | 52 |
|
|
2020
Q4 | $2.91M | Sell |
18,476
-647
| -3% | -$95.5K | 0.35% | 52 |
|
|
2020
Q3 | $2.8M | Buy |
19,123
+210
| +1% | +$31.1K | 0.38% | 57 |
|
|
2020
Q2 | $2.66M | Buy |
18,913
+4,820
| +34% | +$702K | 0.38% | 54 |
|
|
2020
Q1 | $1.85M | Buy |
14,093
+613
| +5% | +$87K | 0.49% | 45 |
|
|
2019
Q4 | $1.97M | Buy |
13,480
+2,127
| +19% | +$288K | 0.5% | 41 |
|
|
2019
Q3 | $1.47M | Buy |
11,353
+880
| +8% | +$116K | 0.4% | 48 |
|
|
2019
Q2 | $1.46M | Sell |
10,473
-293
| -3% | -$40.6K | 0.5% | 43 |
|
|
2019
Q1 | $1.5M | Buy |
10,766
+1,321
| +14% | +$177K | 0.52% | 38 |
|
|
2018
Q4 | $1.22M | Sell |
9,445
-2,040
| -18% | -$285K | 0.45% | 48 |
|
|
2018
Q3 | $1.66M | Sell |
11,485
-2,996
| -21% | -$398K | 0.64% | 31 |
|
|
2018
Q2 | $1.76M | Buy |
14,481
+27
| +0.2% | +$3.37K | 0.65% | 33 |
|
|
2018
Q1 | $1.85M | Sell |
14,454
-154
| -1% | -$20.8K | 0.64% | 35 |
|
|
2017
Q4 | $2.04M | Buy |
14,608
+989
| +7% | +$138K | 0.73% | 26 |
|
|
2017
Q3 | $1.77M | Buy |
+13,619
| New | +$1.81M | 0.7% | 26 |
|
Other funds holding JNJ
Csenge Advisory Group's JNJ Position: Q2 2026 in Review
Csenge Advisory Group reduced its Johnson & Johnson (JNJ) stake by 0.81% in Q2 2026, selling an estimated $34.7K and leaving 18,196 shares worth $4.62M. The position accounts for 0.19% of the portfolio, ranked #111.
Csenge Advisory Group first reported a position in JNJ in Q3 2017 and has held it in 36 quarters since. The position peaked at $4.86M in Q2 2023. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Csenge Advisory Group held 18,196 shares of Johnson & Johnson worth $4.62M as of Q2 2026.
- Csenge Advisory Group sold 149 Johnson & Johnson shares in Q2 2026, an estimated $34.7K.
- Johnson & Johnson made up 0.19% of Csenge Advisory Group's portfolio in Q2 2026, its #111 holding.
- Csenge Advisory Group first reported a position in Johnson & Johnson in Q3 2017 and has held it in 36 quarters since.
- Csenge Advisory Group's Johnson & Johnson position peaked at $4.86M in Q2 2023.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.